217 related articles for article (PubMed ID: 29055222)
1. The cerebrospinal fluid values of advanced oxidation protein products and total thiol content in patients with amyotrophic lateral sclerosis.
Djordjevic G; Ljubisavljevic S; Sretenovic S; Kocic G; Stojanovic I; Stojanovic S
Clin Neurol Neurosurg; 2017 Dec; 163():33-38. PubMed ID: 29055222
[TBL] [Abstract][Full Text] [Related]
2. The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Stojanov D; Stojanovic S; Cvetkovic T; Savic D; Pavlovic D
Neurochem Int; 2013 Jun; 62(7):988-97. PubMed ID: 23500606
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis.
Siciliano G; Piazza S; Carlesi C; Del Corona A; Franzini M; Pompella A; Malvaldi G; Mancuso M; Paolicchi A; Murri L
J Neurol; 2007 May; 254(5):575-80. PubMed ID: 17426914
[TBL] [Abstract][Full Text] [Related]
4. Values of Nitric Oxide and Superoxide Dismutase in Cerebrospinal Fluid of Patients with Sporadic Amyotrophic Lateral Sclerosis.
Djordjevic G; Milosevic V; Ljubisavljevic S; Stojanovic I; Stojanov A
Neurol India; 2023; 71(4):742-747. PubMed ID: 37635508
[TBL] [Abstract][Full Text] [Related]
5. Can Oxidation-Reduction Potential of Cerebrospinal Fluid Be a Monitoring Biomarker in Amyotrophic Lateral Sclerosis?
Opačić M; Stević Z; Baščarević V; Živić M; Spasić M; Spasojević I
Antioxid Redox Signal; 2018 Jun; 28(17):1570-1575. PubMed ID: 29113448
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Zheng Y; Gao L; Wang D; Zang D
Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of soluble RAGE, AGEs and AOPPs at the early stage of amyotrophic lateral sclerosis: A preliminary study.
Juranek J; Osowski A; Wojtkiewicz J; Banach M
Polim Med; 2023; 53(2):105-110. PubMed ID: 38112253
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.
Paladino P; Valentino F; Piccoli T; Piccoli F; La Bella V
Eur J Neurol; 2009 Feb; 16(2):257-61. PubMed ID: 19138331
[TBL] [Abstract][Full Text] [Related]
11. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
[TBL] [Abstract][Full Text] [Related]
13. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
Liu J; Gao L; Zang D
PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation.
Chico L; Ienco EC; Bisordi C; Lo Gerfo A; Petrozzi L; Petrucci A; Mancuso M; Siciliano G
CNS Neurol Disord Drug Targets; 2018; 17(10):767-779. PubMed ID: 30033879
[TBL] [Abstract][Full Text] [Related]
15. Correlation of cerebral spinal fluid pH and HCO3- with disease progression in ALS.
Morimoto N; Deguchi K; Sato K; Yunoki T; Deguchi S; Ohta Y; Kurata T; Takao Y; Ikeda Y; Matsuura T; Abe K
J Neurol Sci; 2011 Aug; 307(1-2):74-8. PubMed ID: 21632065
[TBL] [Abstract][Full Text] [Related]
16. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
[TBL] [Abstract][Full Text] [Related]
20. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
